PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY APPLICATION • Market segmentation by application • Comparison by application • Medical insoles - Market size and forecast 2018-2023 • Sports insoles - Market size and forecast 2018-2023 • Market opportunity by application PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY MATERIAL • Market segmentation by material • Comparison by material • Polypropylene insoles - Market size and forecast 2018-2023 • Leather insoles - Market size and forecast 2018-2023 • Other insoles - Market size and forecast 2018-2023 • Market opportunity by material PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Introduction of connected insoles • Introduction of 3D printing in foot insoles • Growing demand for custom foot insoles PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bauerfeind USA Inc. • Bayer AG • Implus Footcare LLC • SOLO Laboratories, Inc. • SUPERFEET WORLDWIDE, INC. PART 14: APPENDIX • Research methodology • List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Country market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Country market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of rivalry Exhibit 15: Market condition - Five forces 2018 Exhibit 16: Application - Market share 2018-2023 (%) Exhibit 17: Comparison by application Exhibit 18: Medical insoles - Market size and forecast 2018-2023 ($ millions) Exhibit 19: Medical insoles - Year-over-year growth 2019-2023 (%) Exhibit 20: Sports insoles - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Sports insoles - Year-over-year growth 2019-2023 (%) Exhibit 22: Market opportunity by application Exhibit 23: Customer landscape Exhibit 24: Material - Market share 2018-2023 (%) Exhibit 25: Comparison by material Exhibit 26: Polypropylene insoles - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Polypropylene insoles - Year-over-year growth 2019-2023 (%) Exhibit 28: Leather insoles - Market size and forecast 2018-2023 ($ millions) Exhibit 29: Leather insoles - Year-over-year growth 2019-2023 (%) Exhibit 30: Other insoles - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Other insoles - Year-over-year growth 2019-2023 (%) Exhibit 32: Market opportunity by material Exhibit 33: Internet users in the US 2011-2016 (% of the population as of July 25, 2018) Exhibit 34: Impact of drivers and challenges Exhibit 35: Vendor landscape Exhibit 36: Landscape disruption Exhibit 37: Vendors covered Exhibit 38: Vendor classification Exhibit 39: Market positioning of vendors Exhibit 40: Bauerfeind USA Inc. - Vendor overview Exhibit 41: Bauerfeind USA Inc. - Product segments Exhibit 42: Bauerfeind USA Inc. - Organizational developments Exhibit 43: Bauerfeind USA Inc. - Key offerings Exhibit 44: Bayer AG - Vendor overview Exhibit 45: Bayer AG - Business segments Exhibit 46: Bayer AG - Organizational developments Exhibit 47: Bayer AG - Geographic focus Exhibit 48: Bayer AG - Segment focus Exhibit 49: Bayer AG - Key offerings Exhibit 50: Implus Footcare LLC - Vendor overview Exhibit 51: Implus Footcare LLC - Product segments Exhibit 52: Implus Footcare LLC - Organizational developments Exhibit 53: Implus Footcare LLC - Key offerings Exhibit 54: SOLO Laboratories, Inc. - Vendor overview Exhibit 55: SOLO Laboratories, Inc. - Product segments Exhibit 56: SOLO Laboratories, Inc. - Key offerings Exhibit 57: SUPERFEET WORLDWIDE, INC. - Vendor overview Exhibit 58: SUPERFEET WORLDWIDE, INC. - Product segments Exhibit 59: SUPERFEET WORLDWIDE, INC. - Key offerings Exhibit 60: Validation techniques employed for market sizing  

Bauerfeind USA Bayer AG Implus Footcare SOLO Laboratories SUPERFEET WORLDWIDE